|
Aug 15
|
High Growth Tech Stocks To Watch In The US August 2025
|
|
Aug 12
|
Exploring High Growth Tech Stocks In The US Market
|
|
Aug 8
|
US High Growth Tech Stocks To Watch In August 2025
|
|
Aug 6
|
Aldeyra Therapeutics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
|
|
Aug 5
|
Exploring 3 High Growth Tech Stocks In The US Market
|
|
Aug 1
|
High Growth US Tech Stocks To Watch In August 2025
|
|
Jul 31
|
Exploring US High Growth Tech Stocks For July 2025
|
|
Jul 31
|
High Growth Tech Stocks in the US for July 2025
|
|
Jul 30
|
Exploring US High Growth Tech Stocks For Potential Portfolio Expansion
|
|
Jul 30
|
High Growth Tech Stocks in the US Market July 2025
|
|
Jul 29
|
US High Growth Tech Stocks To Watch
|
|
Jul 29
|
US High Growth Tech Stocks To Watch In July 2025
|
|
Jul 24
|
Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Inherited Retinal Dystrophies including Retinitis Pigmentosa
|
|
Jul 17
|
Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics
|
|
Jul 17
|
Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease
|
|
Jul 16
|
5 Small Drug Stocks to Buy Amid Trump's New Tariff Threats
|
|
Jul 15
|
Aldeyra Therapeutics (ALDX) Upgraded to Strong Buy: What Does It Mean for the Stock?
|
|
Jul 15
|
Are Medical Stocks Lagging Amgen (AMGN) This Year?
|
|
Jun 26
|
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Chipmaker Optimism, Eyes Turn to Fed Leadership Speculation
|
|
Jun 26
|
Aldeyra Therapeutics Receives Special Protocol Assessment Agreement Letter from the U.S. Food and Drug Administration for ADX-2191 for the Treatment of Primary Vitreoretinal Lymphoma
|